Buradasınız

Anasayfa » Content

Enterobacteriaceae Üyesi ve Pseudomonas Cinsi Bakterilerin P-Laktam Antibiyotiklere Direnci

The resistance of Enterobacteriaceae members and Pseudomonas species to P-laktam antibiotics

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1997

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
This study was performed in İnönü University Turgut ÖZAL Medical Center to asses the resistance of Enterobacteriaceae and Pseudomonas species to P-laktam antibiotics. From October 1995 to February 1997, 1126 Gram negative bacilli were isolated. 1022 (91) of isolates were Enterobacteriaceae members whereas 104 (9%) of them were Pseudomonas species. Sensitivities of pathogens P-laktam antibiotics were performed by Kirby-Bauer disc diffusion method. Following antibiotics were effective as: ceftazidime, imipenem, cefotaxime, ceftriaxone and cefoxitin for E. coli; imipenem and cefotaxime for Enterobacter species; imipenem, cefoxitin, ceftazidime, and ceftriaxone for Proteus species; imipenem, ceftazidime, cefotaxime, and ceftriaxone for Klebsiella species; imipenem and ceftazidime for Citrobacter species; and cefoperozone-sulbactam and imipenem for Pseudomonas species. [Turgut Özal Tıp Merkezi Dergisi 1997;4(2):193-196]
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışma İnönü Üniversitesi Turgut ÖZAL Tıp Merkezi Mikrobiyoloji Laboratuvarında saflaştırılan Enterobacteriaceae üyelerinin ve Pseudomonas türlerinin P-laktam antibiyotiklere in vitro direncini saptamak amacıyla yapıldı. Ekim-1995 ve Şubat-1997 tarihleri arasında klasik yöntemlerle tanımlanan 1126 Gram (-) basilden 1022'si (% 91) Enterobacteriaceae ailesi üyeleri ve 104'ü (% 9) Pseudomonas türleri idi. Patojenlerin, P-laktam antibiyotiklere karşı duyarlılık testleri Kirby-Bauer disk diffüzyon yöntemi ile yapıldı. Bulgularımıza göre E.coli için seftazidim, imipenem, sefotaksim, seftriakson ve sefoksitin'in; Enterobacter türleri için imipenem ve sefotaksim'in; Proteus'lar için imipenem, sefotaksim, seftazidim ve seftriakson 'un; Klebsiella türleri için imipenem, seftazidim, sefotaksim ve seftriakson'un; Citrobacter türleri için imipenem ve seftazidim 'in ve Pseudomonas türleri için sefaperazon-sulbaktam ve imipenem 'in en etkili olduğu tespit edilmiştir. [Journal of Turgut Özal Medical Center 1997;4(2): 193-196]
FULL TEXT (PDF): 
PDF icon arastirmax-enterobacteriaceae-uyesi-pseudomonas-cinsi-bakterilerin-p-laktam-antibiyotiklere-direnci.pdf
  • 2
193-196
  • Turkish

REFERENCES

References: 

1. Maniatis AN, Trougakos IP, Katsanis G, et al. Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital. Chemotherapy 1997:43 (1); 69¬76.
2. Holloway WJ, Palmer D. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections. Am J Med 1996:100 (6A); 52S-59S.
3. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996:100 (6A): 3S-12S.
4. Schumacher H, Thomsen VF. Resistance of gram-negative bacteria to beta-lactams, aminoglycosides and quinolones Ugeskr Laeger 1994:156 (42); 6185-6190.
5. Sanders CC, Sanders WE Jr, Goering RV, Werner V. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob
Agents Chemother 1984:26 (6); 797-801.
6. Chandrasekar PH, Sluchak JA. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone. Infection 1991:19 (1); 49¬53.
7. Gilbert DN. An evaluation of antipseudomonal antimicrobic
agents. Antibiot Chemother 1985:36: 111-133.
8.
ve Gram
negati
f bakterilerde imipenem duyarlılığı. Turgut Özal Tıp Merkezi Dergisi 1995;2( 1); 17-21.
9. Molinari G, Pugliese V, Schito GC, Guzman CA. Bacteria involved in the blockage of biliary stents and their susceptibility to antibacterial agents. Eur J Clin Microbiol Infect Dis 1996:15 (1); 88-92.
10. Thornsberry C, Yee YC. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med 1996:100 (6A); 26S-38S.

Thank you for copying data from http://www.arastirmax.com